Which Weight Loss Injection Should You Choose in 2026?
Wegovy vs Saxenda: Buy Online UK Comparison Guide
When comparing Wegovy vs Saxenda for online purchase in the UK, the key difference lies in their active ingredients and injection frequency. Wegovy contains semaglutide, a GLP-1 receptor agonist administered once weekly, whilst Saxenda contains liraglutide, requiring daily injections. Both are prescription-only medicines manufactured by Novo Nordisk and available through EverydayMeds' GPhC-registered pharmacy. Weekly Wegovy injections may offer better adherence compared to daily Saxenda, though individual preferences vary significantly.
The decision between Wegovy vs Saxenda often comes down to lifestyle factors and clinical suitability determined during your online assessment. Wegovy's longer half-life allows weekly dosing, which many patients find more convenient for long-term weight management. Saxenda's daily injections provide more frequent dosing control, which some prescribers prefer for certain patients. Both treatments require clinical assessment and ongoing medical supervision through our qualified prescriber network.
Pricing Comparison: Wegovy vs Saxenda Online UK Costs
Wegovy pricing starts from £79.99 for the 0.25mg starter pen, with the maintenance 2.4mg dose costing £209.99 per pen. Saxenda pricing typically ranges from £89.99 to £149.99 per pen depending on current availability. New customers receive discount code FIRST40 at checkout, whilst returning customers use DOSE25 for additional savings. Both medications require prescription approval following our 3-minute online clinical assessment and prescriber review.
Bundle options for Wegovy include the Intro Duo (0.25mg & 0.5mg) at £169.99 and the Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99, providing convenient multi-month supplies. Saxenda is typically purchased as individual pens due to its daily dosing regimen. When comparing monthly costs, Wegovy's weekly injection schedule often proves more economical than Saxenda's daily requirements, though individual treatment duration varies based on clinical response and prescriber guidance.
Clinical Evidence: Wegovy vs Saxenda Weight Loss Trials
In clinical trials, patients taking Wegovy alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across diverse patient populations, including those with type 2 diabetes and cardiovascular risk factors. Wegovy's semaglutide mechanism targets GLP-1 receptors more selectively than earlier GLP-1 agonists.
Saxenda clinical trials showed different weight loss profiles due to its daily liraglutide dosing and shorter duration of action. Both treatments were studied in controlled environments with reduced-calorie diets and increased physical activity. Individual results may vary significantly, and both medications are subject to MHRA additional monitoring with Black Triangle status for ongoing safety surveillance.
How Wegovy vs Saxenda Work: Mechanism Differences
Wegovy's semaglutide acts as a GLP-1 receptor agonist, mimicking natural hormones that regulate appetite and blood sugar levels. The medication may help reduce appetite, promote feelings of fullness after smaller meals, and potentially decrease food cravings by working on brain appetite centres. Semaglutide has a longer half-life than liraglutide, allowing once-weekly administration through Novo Nordisk's FlexTouch pen system. Weekly dosing may improve treatment adherence compared to daily injection regimens. The dose escalation schedule progresses from 0.25mg to 2.4mg over 16 weeks to minimise gastrointestinal side effects. Both medications require prescription oversight and cannot be used without proper medical supervision.
Online Ordering Process: Wegovy vs Saxenda UK Purchase
Purchasing either Wegovy or Saxenda through EverydayMeds begins with our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our GPhC-registered prescribers (#9012878) review your assessment within 3 working days (or 24 hours with express service) to determine treatment suitability and dosing recommendations. Once approved, your prescription-only medicine ships via next-day cold-chain delivery maintaining the required 2-8°C temperature throughout transport. Payment includes the clinical consultation, prescriber review, genuine Novo Nordisk medication, and temperature-controlled delivery to your chosen address. Our pharmacy team provides ongoing support throughout your treatment journey, including dose adjustment guidance and side effect management.
Storage and Practical Considerations: Wegovy vs Saxenda
Both Wegovy and Saxenda require refrigerated storage at 2-8°C before first use, with Wegovy offering superior travel flexibility through its 6-week room temperature stability once removed from the fridge. Saxenda typically provides 30 days of room temperature storage, making Wegovy more convenient for extended travel or workplace storage. Both medications use Novo Nordisk's FlexTouch pen technology, though Wegovy's weekly dosing reduces injection frequency significantly. Proper disposal of used pens through pharmaceutical waste collection ensures environmental safety and regulatory compliance. Dose escalation schedules differ between treatments, with Wegovy requiring 16 weeks to reach maintenance dosing compared to Saxenda's shorter titration period. Pre-filled pens eliminate dosing errors common with vial-based medications.
UK Regulatory Status: Wegovy vs Saxenda Online Availability
Both Wegovy and Saxenda hold MHRA marketing authorisation for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. NICE guidance TA875 recommends Wegovy within specialist weight management services, whilst Saxenda has established NICE approval under TA664. Online prescribing through registered pharmacies like EverydayMeds (#9012878) provides legitimate access to both treatments following proper clinical assessment. Private prescriptions allow faster access than NHS pathways, which often have lengthy waiting lists and strict eligibility criteria.
Recent MHRA approval of Wegovy's 7.2mg higher-strength dose (January 2026) expands treatment options for patients requiring enhanced efficacy, though this formulation remains under evaluation for EverydayMeds availability. Both medications maintain Black Triangle status requiring enhanced safety monitoring and adverse event reporting. Purchasing from unregulated sources risks counterfeit medications lacking proper storage, sterility, and active ingredient verification essential for prescription-only medicines.
Make Your Choice: Order Wegovy vs Saxenda Today
Ready to start your weight management journey with either Wegovy or Saxenda? Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover which treatment aligns with your lifestyle and medical needs. Use discount code FIRST40 at checkout for new customers or DOSE25 for returning patients to access our competitive pricing starting from £79.99. Our expert prescribers will guide your treatment selection based on your individual circumstances, ensuring safe and effective weight management support. Don't wait – take the first step towards your health goals with confidence through the UK's trusted online weight management pharmacy. Both Wegovy and Saxenda are available from EverydayMeds with professional prescriber support to help determine which treatment is right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
